D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
TAK holding history
Takeda Pharmaceutical Co Ltd in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TAK overviewAll 13F holders of TAKFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,049,467
- Value
- $32.9M
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,049,467 | $32.9M | <0.1% | −553,076−21.3% | Reduced | Holders |
| Q1 2026 | 2,602,543 | $48.2M | <0.1% | −1,691,207−39.4% | Reduced | Holders |
| Q4 2025 | 4,293,750 | $66.9M | 0.1% | +4,012,456+1,426.4% | Added | Holders |
| Q3 2025 | 281,294 | $4.12M | <0.1% | +281,294 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −56,036−100.0% | Sold out | Holders |
| Q1 2025 | 56,036 | $833.3K | <0.1% | +56,036 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −122,354−100.0% | Sold out | Holders |
| Q3 2024 | 122,354 | $1.74M | <0.1% | +122,354 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −354,299−100.0% | Sold out | Holders |
| Q1 2024 | 354,299 | $4.92M | <0.1% | +139,342+64.8% | Added | Holders |
| Q4 2023 | 214,957 | $3.07M | <0.1% | −52,938−19.8% | Reduced | Holders |
| Q3 2023 | 267,895 | $4.14M | <0.1% | −19,224−6.7% | Reduced | Holders |
| Q2 2023 | 287,119 | $4.51M | <0.1% | −123,295−30.0% | Reduced | Holders |
| Q1 2023 | 410,414 | $6.76M | <0.1% | +410,414 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −237,726−100.0% | Sold out | Holders |
| Q1 2022 | 237,726 | $3.40M | <0.1% | +47,415+24.9% | Added | Holders |
| Q4 2021 | 190,311 | $2.59M | <0.1% | +190,311 | New | Holders |